Sanofi and QuantHealth Team up to Advance AI-Powered Digital Twins and Clinical Trials Simulations to Accelerate Drug Development
QuantHealth, a pioneer in AI-driven clinical trial simulation, announced a strategic investment from Sanofi Ventures, the venture…
BenchSci signs license agreement with Sanofi for drug development platform | Mobi Health News
Skip to main content…
Continue Reading
QuantHealth, Sanofi Ventures team up to advance clinical trial simulations | Mobi Health News
Skip to main content…
Continue Reading
What You Should Know:
– Sanofi Ventures has announced a significant $625M multi-year capital commitment from Sanofi, substantially increasing its total assets under management (AUM) to over $1.4B.
– The new capital injection into the evergreen…
Continue Reading
What You Should Know:
– Sanofi has entered into an agreement to acquire Vicebio Ltd (“Vicebio”), a privately held biotechnology company headquartered in London, UK. The acquisition expands Sanofi’s capabilities in vaccine design and development…
Continue Reading
AI-backed imaging and care coordination company Viz.ai is partnering with biotechnology company Regeneron and biopharmaceutical company Sanofi to deploy and study an AI-enabled workflow tool for COPD. Viz.ai offers a care coordination platform with more…
Continue Reading
San Francisco-based data intelligence and AI provider Databricks has raised $10 billion of expected non-dilutive financing in a Series J funding round, completing $8.6 billion to date. The new funding brings the company’s valuation…
Continue Reading
What You Should Know:
– BrightInsight, Inc., a provider of regulated digital health solutions, has announced an expanded multi-year partnership with Sanofi, a global biopharmaceutical company. This expanded partnership builds on a successful collaboration that…
Continue Reading
Expert Health Tech Leader Brings Extensive Experience in Connected Care, Life Sciences, and Chronic Condition Management to Drive Global Growth
Glooko, Inc., a global integrated digital health company connecting patients, providers, biopharma, and medical device…
Glooko, the maker of a digital platform for managing diabetes and other chronic diseases, has secured $100 million in Series F funding and announced Mike Alvarez as the company’s newly appointed CEO. Georgian led the…
Continue Reading
